Literature DB >> 26712492

Troponin elevation predicts critical care needs and in-hospital mortality after thrombolysis in white but not black stroke patients.

Roland Faigle1, Elisabeth B Marsh2, Rafael H Llinas3, Victor C Urrutia4, Rebecca F Gottesman5.   

Abstract

INTRODUCTION: Stroke patients undergoing intravenous thrombolysis (IVT) are at increased risk for critical care interventions and mortality. Cardiac troponin elevation is common in stroke patients; however, its prognostic significance is unclear. The present study evaluates troponin elevation as a predictor of critical care needs and mortality in post-IVT patients and describes racial differences in its predictive accuracy.
METHODS: Logistic regression and receiver operating characteristics (ROC) analysis were used to determine racial differences in the predictive accuracy of troponin elevation for critical care needs and mortality in post-IVT patients.
RESULTS: Troponin elevation predicted critical care needs in white (odds ratio [OR] 29.40, 95% confidence interval [CI] 4.86-177.81) but not black patients (OR 0.50, 95% CI 0.14-1.78; P value for interaction < .001). Adding troponin elevation to a prediction model for critical care needs in whites improved the area under the curve from 0.670 to 0.844 (P = .006); however, addition of troponin elevation did not improve the model in blacks (area under the curve 0.843 vs 0.851, P = .54). Troponin elevation was associated with in-hospital mortality in whites (OR 21.94, 95% CI 3.51-137.11) but not blacks (OR 1.10, 95% CI 0.19-6.32, P value for interaction .022).
CONCLUSION: Troponin is a useful predictor of poor outcome in white but not black post-IVT stroke patients.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Critical care needs; IV thrombolysis; Racial differences; Racial disparities; Stroke; Troponin

Mesh:

Substances:

Year:  2015        PMID: 26712492      PMCID: PMC4769902          DOI: 10.1016/j.jcrc.2015.11.012

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  23 in total

1.  Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

Authors:  Christopher R deFilippi; James A de Lemos; Robert H Christenson; John S Gottdiener; Willem J Kop; Min Zhan; Stephen L Seliger
Journal:  JAMA       Date:  2010-11-15       Impact factor: 56.272

2.  Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).

Authors:  V Larrue; R von Kummer R; A Müller; E Bluhmki
Journal:  Stroke       Date:  2001-02       Impact factor: 7.914

3.  Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke.

Authors:  M Barber; J J Morton; P W Macfarlane; N Barlow; G Roditi; D J Stott
Journal:  Cerebrovasc Dis       Date:  2006-12-29       Impact factor: 2.762

4.  Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke.

Authors:  E Di Angelantonio; M Fiorelli; D Toni; M L Sacchetti; S Lorenzano; A Falcou; M V Ciarla; M Suppa; L Bonanni; G Bertazzoni; F Aguglia; C Argentino
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

5.  Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis.

Authors:  Thorleif Etgen; Hannsjoerg Baum; Kerstin Sander; Dirk Sander
Journal:  Stroke       Date:  2004-12-16       Impact factor: 7.914

6.  Creatine kinase-MB elevation after stroke is not cardiac in origin: comparison with troponin T levels.

Authors:  Hakan Ay; Ethem Murat Arsava; Okay Saribaş
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

7.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

8.  Multiple imputation using chained equations: Issues and guidance for practice.

Authors:  Ian R White; Patrick Royston; Angela M Wood
Journal:  Stat Med       Date:  2010-11-30       Impact factor: 2.373

9.  Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Edward C Jauch; Jeffrey L Saver; Harold P Adams; Askiel Bruno; J J Buddy Connors; Bart M Demaerschalk; Pooja Khatri; Paul W McMullan; Adnan I Qureshi; Kenneth Rosenfield; Phillip A Scott; Debbie R Summers; David Z Wang; Max Wintermark; Howard Yonas
Journal:  Stroke       Date:  2013-01-31       Impact factor: 7.914

10.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.